 AUSTIN, Texas, Sept. 23, 2021 GLOBE NEWSWIRE -- Plus Therapeutics, Inc. Nasdaq: PSTV the Company, a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced it will present data regarding its Rhenium-186 NanoLiposome 186RNL investigational radiotherapeutic for recurrent glioblastoma GBM at the American Society for Radiation Oncology ASTRO 2021 Annual Meeting being held in person October 24-27, 2021 in Chicago, Illinois. 